Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment
Glaucoma is one of the world’s primary causes of blindness. Russia is following the global increasing trends of glaucoma and its leading position among ophthalmic pathologies that cause irreversible loss of vision. Elevated intraocular pressure (IOP) is the only modifiable risk factor of glaucoma, s...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2024-07-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1505 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395992269422592 |
|---|---|
| author | S. Yu. Petrov O. M. Fillipova T. N. Malishevskaya O. I. Markelova |
| author_facet | S. Yu. Petrov O. M. Fillipova T. N. Malishevskaya O. I. Markelova |
| author_sort | S. Yu. Petrov |
| collection | DOAJ |
| description | Glaucoma is one of the world’s primary causes of blindness. Russia is following the global increasing trends of glaucoma and its leading position among ophthalmic pathologies that cause irreversible loss of vision. Elevated intraocular pressure (IOP) is the only modifiable risk factor of glaucoma, so treatment strategies specifically focus on reducing IOP by suppressing the production of intraocular fluid and boosting its outflow. The current review presents new medications aimed at glaucoma and high IOP control that have recently appeared at the international market as well as the drugs under the different stages of development, from experimental to clinical studies. These include both the developments of agents belonging to the existing classes and of entirely new drugs intended to control IOP. In an attempt to reduce the side effects of locally administered drugs and prolong their action, in parallel with the development of new drugs, there is also evidence of alternative methods of drug delivery: intraocular implants, injectable forms and obturators, combinations of polymers and colloidal systems. |
| format | Article |
| id | doaj-art-3d3335c04f3845ab92e6175dabc1c16d |
| institution | Kabale University |
| issn | 2072-0076 2587-5760 |
| language | Russian |
| publishDate | 2024-07-01 |
| publisher | Real Time Ltd |
| record_format | Article |
| series | Российский офтальмологический журнал |
| spelling | doaj-art-3d3335c04f3845ab92e6175dabc1c16d2025-08-20T03:39:28ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602024-07-0117215415910.21516/2072-0076-2024-17-2-154-159702Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatmentS. Yu. Petrov0O. M. Fillipova1T. N. Malishevskaya2O. I. Markelova3Helmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesGlaucoma is one of the world’s primary causes of blindness. Russia is following the global increasing trends of glaucoma and its leading position among ophthalmic pathologies that cause irreversible loss of vision. Elevated intraocular pressure (IOP) is the only modifiable risk factor of glaucoma, so treatment strategies specifically focus on reducing IOP by suppressing the production of intraocular fluid and boosting its outflow. The current review presents new medications aimed at glaucoma and high IOP control that have recently appeared at the international market as well as the drugs under the different stages of development, from experimental to clinical studies. These include both the developments of agents belonging to the existing classes and of entirely new drugs intended to control IOP. In an attempt to reduce the side effects of locally administered drugs and prolong their action, in parallel with the development of new drugs, there is also evidence of alternative methods of drug delivery: intraocular implants, injectable forms and obturators, combinations of polymers and colloidal systems.https://roj.igb.ru/jour/article/view/1505glaucomaglaucomatous neuropathyblindnessophthalmic hypertensionmedicinal preparationsdevelopment of agentadherence to treatment |
| spellingShingle | S. Yu. Petrov O. M. Fillipova T. N. Malishevskaya O. I. Markelova Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment Российский офтальмологический журнал glaucoma glaucomatous neuropathy blindness ophthalmic hypertension medicinal preparations development of agent adherence to treatment |
| title | Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| title_full | Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| title_fullStr | Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| title_full_unstemmed | Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| title_short | Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| title_sort | current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment |
| topic | glaucoma glaucomatous neuropathy blindness ophthalmic hypertension medicinal preparations development of agent adherence to treatment |
| url | https://roj.igb.ru/jour/article/view/1505 |
| work_keys_str_mv | AT syupetrov currenttrendsandprospectsofthelocalantihypertensivedrugsdevelopmentfortheglaucomatreatment AT omfillipova currenttrendsandprospectsofthelocalantihypertensivedrugsdevelopmentfortheglaucomatreatment AT tnmalishevskaya currenttrendsandprospectsofthelocalantihypertensivedrugsdevelopmentfortheglaucomatreatment AT oimarkelova currenttrendsandprospectsofthelocalantihypertensivedrugsdevelopmentfortheglaucomatreatment |